Copyright © 2007 by The Journal of Bone and Joint Surgery, Inc.
Commentary & Perspective
Commentary & Perspective by
Frederick A. Matsen III, MD*,
University of Washington, Seattle, Washington
Posted April 2007
At a time when implant costs are soaring, when glenoid
component failure remains an unsolved problem in total shoulder arthroplasty1,2,
when arthritis secondary to arthroscopic and other surgical misadventures is
creating yet younger individuals with loss of glenohumeral articular cartilage,
when individuals of all ages are putting shoulder arthroplasties to greater and
greater functional demands, and when newer implant designs are increasingly
expensive, it is indeed timely to consider whether there is a better way to
manage the concave side of the arthritic glenohumeral joint.
A new approach to glenoid arthroplasty needs to be tested
against rigorous criteria: (1) the clinical outcomes need to compare favorably
with existing techniques, (2) the surface must be durable, (3) the surface must
be firmly fixed to the subjacent bone, (4) the surface must effectively
distribute the humeral load to the bone of the glenoid, (5) the surface must
provide sufficient intrinsic stability to enable the concavity compression
mechanism to center the humeral head in the glenoid, and (6) the new solution
cannot be associated with more complications than current solutions.
We are indebted to Krishnan et al. for bringing forward a
creative option for our consideration. The concept of resurfacing the glenoid
with a biological rather than a prosthetic surface is exciting in that it offers
the possibility of meeting each of the above criteria as well as allowing
repair and remodeling with use—attributes that can never be incorporated into
nonbiological components.
These authors present a series of patients with primary or
secondary glenohumeral degenerative joint disease treated with a variety of
biological materials (local capsular flap, autogenous fascia lata, and Achilles
tendon allograft) interposed between a prosthetic humeral head and glenoid
bone. At the time of surgery, the glenoid bone was decorticated to a bleeding
surface and the graft was secured to four points on the glenoid periphery. A
standard humeral hemiarthroplasty was then performed.
In terms of clinical outcomes, the American Shoulder and
Elbow Surgeons (ASES) scores and Neer scores obtained by Krishnan et al.
matched or exceeded those recently reported in this journal for total shoulder
arthroplasty (Tables I and II). This is remarkable, considering that five of
the thirty-six shoulders had unsatisfactory Neer scores, three had
postoperative instability, two had infection, and one had brachial plexitis.
The results can also be characterized in terms of the five
other suggested criteria for evaluating the options for glenoid arthroplasty.
1. Durability: The average radiographic joint space
diminished from 2.9 mm immediately after surgery to 1.3 mm at the time of the most
recent follow-up. It is not clear whether the residual radiographic joint space
was occupied by the original interpositional material or by new tissue
ingrowth.
2. Fixation to bone: No data were provided on the degree to
which the grafts healed and remained fixed to the subjacent bone.
3. Load distribution: Glenoid erosion averaged 7.2 mm,
apparently becoming stable after several years. It may be that this erosion
takes place until the load is evenly distributed across the surface of the
glenoid bone.
4. Intrinsic stability: Three of the thirty-six shoulders
demonstrated postoperative instability. It is not clear whether this procedure
re-establishes the glenoid concavity or whether these cases of instability were
due to lack of effective concavity or to other causes.
5. New problems: Of the seven shoulders in which autogenous
anterior capsule was used, three became unstable and one became infected. One
of eleven shoulders in which autogenous fascia lata was used became infected.
Finally, although no donor site complications were reported, harvesting of
autograft from a distant site does require a second incision. By contrast there
were no unsatisfactory results in the shoulders that received Achilles tendon
allograft.
In conclusion, this paper encourages shoulder surgeons to
continue to pursue cost-effective solutions for the management of the wide
range of individuals with debilitating glenohumeral arthritis and to seek
robust and consistent methods for evaluating outcomes in a way that enables
comparison among procedures, patients, and surgeons. This is particularly true
of efforts, such as that described in this paper, to address the unsolved
concave side of the arthroplasty. As additional procedures, including nonprosthetic
glenoid resurfacing and humeral hemiarthroplasty (the so-called "ream-and-run"
procedure) and meniscus allograft, come to the fore, the rigor of analysis will
become even more important.
*The author did not receive any outside funding or grants in
support of his research for or preparation of this work. Neither he nor a
member of his immediate family received payments or other benefits or a
commitment or agreement to provide such benefits from a commercial entity. A
commercial entity (DePuy) paid or directed in any one year, or agreed to pay or
direct, benefits in excess of $10,000 to a research fund, foundation, division,
center, clinical practice, or other charitable or nonprofit organization with
which one or more of the authors, or a member of his or her immediate family,
is affiliated or associated.
References
1. Bohsali KI, Wirth MA, Rockwood CA Jr. Complications of total shoulder arthroplasty. J Bone Joint Surg Am. 2006;88:2279-92.
2. Hasan SS, Leith JM, Campbell B, Kapil R, Smith KL, Matsen FA 3rd. Characteristics of unsatisfactory shoulder arthroplasties. J Shoulder Elbow Surg. 2002;11:431-41.
3. Gartsman GM, Roddey TS, Hammerman SM. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis. J Bone Joint Surg Am. 2000;82:26-34.
4. Martin SD, Zurakowski D, Thornhill TS. Uncemented glenoid component in total shoulder arthroplasty: survivorship and outcomes. J Bone Joint Surg Am. 2005;87:1284-92.
5. Lo IK, Litchfield RB, Griffin S, Faber K, Patterson SD, Kirkley A. Quality-of-life outcome following hemiarthroplasty or total shoulder arthroplasty in patients with osteoarthritis: a prospective, randomized trial. J Bone Joint Surg Am. 2005;87:2178-85.
6. Sperling JW, Cofield RH, Rowland CM. Neer hemiarthroplasty and Neer total shoulder arthroplasty in patients fifty years old or less. Long-term results. J Bone Joint Surg Am. 1998;80:464-73.
| Table I American Shoulder and Elbow Surgeons (ASES) Scores* |
| Authors |
Mean ASES Score |
Mean age (yr) |
Mean follow-up (yr) |
| Preoperative |
Postoperative |
| Krishnan et al. (2007) |
|
|
|
|
| Hemi |
39 |
91 |
51 |
7 |
| Gartsman et al.3 (2000) |
|
|
|
|
| TSA |
22.7 |
77.3 |
65.3 |
3 |
| Hemi |
22.6 |
65.2 |
64.6 |
2.8 |
| Martin et al.4 (2005) |
|
|
|
|
| TSA |
15.6 |
75.8 |
63.3 |
7.5 |
| Lo et al.5 2005 |
|
|
|
|
| TSA |
30.7 |
91.1 |
70.4 |
2 |
| Hemi |
31.1 |
83.1 |
70.3 |
2 |
| *TSA = Total shoulder arthroplasty. Hemi = Hemiarthroplasty. |
| Table II Neer Scores* |
| Authors |
Neer Score |
Mean age (yr) |
Mean follow-up (yr) |
Excellent (no. of shoulders) |
Satisfactory (no. of shoulders) |
Unsatisfactory (no. of shoulders) |
| Krishnan et al. (2007) |
|
|
|
|
|
| Hemi |
18 |
13 |
5 |
51 |
7 |
| Sperling et al.6 (1998) |
|
|
|
|
|
| TSA |
4 |
13 |
17 |
41 |
12.3 |
| Hemi |
15 |
24 |
35 |
39 |
12.3 |
| *TSA = Total shoulder arthroplasty. Hemi = Hemiarthroplasty. |
|